Founding Date | Founding Date 2003 | Founding Date 2000 | Founding Date 1904 |
Type | Type Public | Type Public | Type Subsidiary |
Tags | |||
Locations | Locations Radnor, US HQ | Locations Tübingen, DE HQ Ottignies Louvain La Neuve, BE Wiesbaden, DE Amsterdam, NL Basel, CH Boston, US | Locations King of Prussia, US HQ Broadmeadows, AU Parkville, AU Parkville, AU Wien, AT Mechelen, BE see more |
Employees | Employees 402% decrease | Employees 82517% decrease | Employees 7,5692% decrease |
Valuation ($) | Valuation ($) 16 m | Valuation ($) 648.3 m | Valuation ($) N/A |
Financial | |||
Revenue (est.) | Revenue (est.) $31m (FY, 2023) | Revenue (est.) €535.2m (FY, 2024) | Revenue (est.) $7.9b (FY, 2020) |
Gross profit | Gross profit N/A | Gross profit €534.4m (FY, 2024) | Gross profit $4.5b (FY, 2020) |
Net income | Net income ($141.4m) (FY, 2023) | Net income €162.2m (FY, 2024) | Net income N/A |
Operating ⚠ | |||
Patent Applications | Patent Applications N/A | Patent Applications 500 (Mar, 2020) | Patent Applications 3 (Dec, 2020) |
Funding | |||
Total funding raised | Total funding raised $ 81.8m | Total funding raised $ 1.1b | Total funding raised N/A |

CureVac is a biotechnology company offering messenger RNA (mRNA) technology.
View company